Rick Shinto & Penelope Kokkinides Improving InnovaCare

Rick Shinto M.D., MBA, President and CEO of InnovaCare Inc. Previously he worked as CEO of Aveta Inc. Prior to that Dr. Shinto has served as Chief of Medical Officer of NAMM California. Before NAMM, he worked for Medical Pathways Management Company. Alongside him at InnovaCare Health partner Penelope Kokkinides Chief Administrative Officeer. Prior to joining InnovaCare Inc. she worked for Centerlight Health where she was responsible for overall management.

Rick Shinto has received Ernst and Young Entrepreneur of the Year award. Also he received the Access to Caring award at the University of Health Science. The considered winner in achievement for advancement in health care services to the poor.

Penelope Kokkinides has extensive knowledge and expertise in clinical programs and managing healthcare processes and operations with focus of improving organizational infrastructure. Kokkinides has a bachelor’s degree in biological sciences and classical languages from Binghamton University. From the New York University she earned her master’s degree in social work. also she earned a post master’s degree in alcohol and substance abuse. Penelope Kokkinides brings idea’s to life with her team to develop ideas.

New additions to InnovaCare’s leadership are Jonathon Meyers as chief actuary officer, Mike Sortiono chief accounting officer and Penelope Kokkinides as chief administrative. InnovaCare joins HHS Initiative to reform payment methods. InnovaCare supports the LAN’s mission to accelerate the transition to the alternative payment methods. InnovaCare Inc. provides managed health care services. InnovaCare Health values are patients come first quality medical care and teams make the most impact. InnovaCare operates leading health plans like MMM Healthcare, Inc., and PMC Medicare Choice, Inc. Offering seniors comprehensive benefits that not only meet their medical needs but also contribute to their emotional and mental well-being.

With Rick Shinto and Penelope Kokkinides leading the way to success. The two make a in-beatable team with their knowledge and care of others.

The company strives to ensure patients better health and recovery. Through two primary avenues of care, Provider Networks and Medicare Advantage, we are committed to quality healthcare by creating models that are sustainable, cost-effective and fully integrated with advanced technologies.

The Outstanding Company – Securus Technologies

When the correction facilities need assistance at their locations, they call upon Securus Technologies. This company is the leader in the public safety industry, and they do a great job in the civil and criminal sectors of justice. They create new technologies on a weekly basis, and they are helping in many ways all across the country. They have created a great technology that is helping in many ways. It is called Video Visitations.


The Video Visitations are being used by many of the company’s customers across the country. It is helping to keep the inmates in better moods, and thus, it keeps the environment safer for everyone. With the technology, the visitors of the inmates can see and hear them, and they can communicate about all types of different things that are happening. The correction facilities are so happy with how the technology is helping them.


Securus Technologies is respected around the world for what they can do in the public safety field. In the states, the government uses them on a regular basis, and the company is in contact with incarcerated people all the time. They are sure that they can make the world a safer place, and with their dedicated and professional staff, they will surely reach this goal. People will surely hear more about this company in the future.

Mikhail Blagosklonny: A Review of His Life Achievements

Mikhail Blagosklonny is currently professor of Oncology at the Roswell Park Cancer Institute. He was appointed to this position since 15th April 2009. Prior to this coveted appointed he was a Senior Scientist at the Ordway Research Institute in Albany, New York.

Shortly before he took up this job in the year 2002, he was appointed Associate Professor of Medicine at New York Medical College situated at Valhalla in New York.He is an Editor-in Chief of Oncotarget. He also seats in the journal’s Editorial Board of Cell Death and Differentiation. Read more on Impact Journals.

He is also an Associate Editor of Cancer Biology and Therapy of the same journal. He doubles up as the Founder Editor and Editor in Chief of Cell Cycle journal. Mikhail Blagosklonny is an alumnus of First Pavlov State Medical University of St Petersburg. He graduated with an M.D. in Internal Medicine and a PhD in Experimental Medicine and Cardiology. He is well known for his role in TOR signalling in aging and cancer.

He is even more renowned for his advocacy of the use of the cancer drug Rapamycin for possible longevity of life. He has done a lot of research on cancer and target cancer therapies. He has done research on Biogerontology (Mechanisms of Aging) and has proposed Rapamycin as an anti-aging drug.

He holds many publications under his name. He has published more than 270 papers. He is recorded as having used more than 25,000 citations. He thus holds an h-index of 83.From the foregoing, it is clear that Mikhail Blagosklonny is an accomplished Physician, Scientist and Professor of Medicine and Oncology.

He has risen through the ranks with various top-notch appointments. He now holds the position of Professor of Oncology at the Roswell Park Cancer Institute. He continues to write more publications having written more than 270 paper hitherto. He is passionate in Biogerontology and has even proposed use of Rapamycin to elongate life. View Mikhail’s profile in LinkedIn

How EOS Become the Millennial’s Chapstick

EOS is one of the most popular lip balms. The article, The Untold Story of How Lip Balm Upstart EOS Outdid Chapstick, talks about how this company found success in a market full of competition. In that article, they go over how they successfully targeted millennial’s to use their product.

How Did They Target Millennials?

EOS lip balm targeted millennials because of the amount of buyers in that age range. They got to know how the millennial found out information and using strategic marketing tools. One of the tools was contacting influencers, like YouTubers and Instagrammers with big followings, and asking them to review their product. This form of marketing was not really being used yet, and the results were very profitable for EOS. They were able to reach their target audience through a way that was more effective than basic magazine ads.

EOS lip balm built a large social media presence. They have almost two million Instagram followers and almost seven million facebook followers. This allows them to instantly get a message out to their audience, and easily allows them to create buzz when a new product or flavor is about to launch.

Utilizing tools to effectively reach their target audience has benefited EOS by making them the second best-selling lip balm on the market. Their use of marketing strategies to reach potential buyers was wildly successful and innovative at the time.

EOS products are available online on eBay, evolutionofsmooth.com website and http://www.ulta.com/smooth-sphere-lip-balm?productId=xlsImpprod3490245.